secwatch.observer — SEC 8-K summary
======================================

Issuer:     Apimeds Pharmaceuticals US, Inc. (APUS)
CIK:        0001894525
Form:       8-K
Filed at:   2025-05-20T23:59:59+00:00
Accession:  0001213900-25-045643
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Apimeds extends maturity of three promissory notes to May 19, 2026
------------------------------------------------------------------

- Amended notes from Inscobee ($100k and $150k) and Apimeds Korea ($250k), total $500k principal.
- Original maturity dates extended to May 19, 2026; interest remains 5% per annum.
- May 2024 and August 2024 notes were due May 19, 2025; March 2025 note was due Dec 31, 2026 or upon NYSE listing.
- Amendments executed on May 16, 2025, avoid imminent default on two notes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1894525/000121390025045643/0001213900-25-045643-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1894525/000121390025045643/ea024276701-8k_apimed.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-045643

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer